You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

imatinib

Showing 26 - 50 of 124
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Treatment, Stem Cell Transplantation Trial in Italy (Nilotinib, Imatinib)

Completed
  • Treatment
  • Stem Cell Transplantation
  • Ancona, Italy
  • +34 more
Oct 10, 2022

Philadelphia Chromosome Positive CML, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in France (Ponatinib, Imatinib)

Recruiting
  • Philadelphia Chromosome Positive CML
  • BCR-ABL Positive Chronic Myelogenous Leukemia
  • Amiens, France
  • +27 more
Dec 9, 2021

Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt

Completed
  • Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
  • Imatinib
  • Cairo, Egypt
    National Cancer Institute (NCI)
Feb 22, 2021

Chronic Myeloid Leukemia Trial in New Zealand (Dasatinib, Imatinib)

Recruiting
  • Chronic Myeloid Leukemia
  • Auckland, New Zealand
  • +8 more
Mar 10, 2021

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Frankfurt (Main) (Rituximab, Nelarabine, PEG-Asparaginase)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Frankfurt (Main), Germany
    University Hospital of Frankfurt (Main)
Jul 1, 2022

Pulmonary Arterial Hypertension Trial in Worldwide (Imatinib, Sildenafil, Bosentan)

Completed
Has Results
  • Pulmonary Arterial Hypertension
  • Imatinib
  • +2 more
  • Tampa, Florida
  • +10 more
Jun 17, 2021

Acute Lymphoblastic Leukemia, Adult Trial (Ponatinib, Blinatumomab, Imatinib)

Not yet recruiting
  • Acute Lymphoblastic Leukemia, Adult
  • (no location specified)
Dec 28, 2020

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia in Remission, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in Moscow

Active, not recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Imatinib
  • +3 more
  • Moscow, Russian Federation
    National Research Center for Hematology
Oct 1, 2020

Hematologic Malignancy Trial in United States (BBI608, Dexamethasone, Bortezomib)

Completed
  • Hematologic Malignancy
  • Denver, Colorado
  • +7 more
Apr 4, 2022

Unspecified Adult Solid Tumor Trial in San Francisco (bevacizumab, cyclophosphamide, imatinib)

Completed
  • Unspecified Adult Solid Tumor
  • bevacizumab
  • +2 more
  • San Francisco, California
    UCSF Helen Diller Family Comprehensive Cancer Center
Jul 24, 2020

Maximum Tolerated Dose, GIST, Metastatic Adult Soft Tissue Sarcoma Trial in Spain (Selinexor, Imatinib)

Recruiting
  • Maximum Tolerated Dose
  • +4 more
  • Sevilla, Andalucia, Spain
  • +5 more
Oct 21, 2020

Acute Lymphoblastic Leukemia Ph Positive Trial in Spain (Imatinib)

Recruiting
  • Acute Lymphoblastic Leukemia Ph Positive
  • Imatinib
  • Oviedo, Asturias, Spain
  • +80 more
Jan 17, 2022

Acute Lymphoblastic Leukemia Trial in Canada, United States (Doxorubicin, Cytarabine, Methotrexate)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • Boston, Massachusetts
  • +14 more
Jul 25, 2022

GVHD Trial in Stanford, Seattle (Imatinib)

Completed
  • Graft vs Host Disease
  • Imatinib
  • Stanford, California
  • +1 more
Apr 13, 2020

Gastrointestinal Stromal Tumors Trial in Seoul (Imatinib, Placebo)

Completed
Has Results
  • Gastrointestinal Stromal Tumors
  • Imatinib
  • Placebo
  • Seoul, Songpa-gu, Korea, Republic of
    Asan Medical Center
Jan 6, 2020

Fibromatosis Trial in Seoul (Imatinib)

Completed
  • Fibromatosis
  • Imatinib
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Jan 10, 2020

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in United States (Bosutinib, Dasatinib, Laboratory Biomarker

Active, not recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Anchorage, Alaska
  • +540 more
Dec 14, 2022

Colonic Tumors Trial in Amersfoort, Utrecht (Imatinib)

Terminated
  • Colonic Neoplasms
  • Imatinib
  • Amersfoort, Utrecht, Netherlands
  • +2 more
Oct 9, 2019

Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Trial in Worldwide (Imatinib, Nilotinib, Bosutinib)

Recruiting
  • Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
  • Imatinib
  • +4 more
  • Longmont, Colorado
  • +128 more
Aug 1, 2022

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Uijeongbu si (Asciminib single agent, Asciminib, Imatinib)

Recruiting
  • Chronic Myelogenous Leukemia
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Asciminib single agent
  • +5 more
  • Ann Arbor, Michigan
  • +49 more
Jan 26, 2023

Patients Who Have Received Allo-HSCT Trial in Taiwan (Imatinib, Placebo)

Terminated
  • Patients Who Have Received Allo-HSCT
  • Imatinib
  • Placebo
  • Hualien City, Taiwan
  • +4 more
Sep 9, 2019

Chronic Myeloid Leukemia Trial in Germany (Imatinib, Nilotinib)

Terminated
  • Chronic Myeloid Leukemia
  • Aachen, Germany
  • +17 more
Nov 27, 2019

Imatinib: Development of Late Side Effects and Compliance to

Completed
  • Chronic Myeloid Leukemia
  • Newly Diagnosed
  • Imatinib
  • London, United Kingdom
    Haematology Department. Catherine Lewis Centre. Hammersmith Hosp
Jul 3, 2019

Relapsed Pediatric Solid Tumor, Refractory Pediatric Solid Tumor, Relapsed Pediatric AML Trial in Seoul (CancerSCAN™,

Recruiting
  • Relapsed Pediatric Solid Tumor
  • +3 more
  • CancerSCAN™
  • +17 more
  • Seoul, Korea, Republic of
    Samsung Medical Center
Mar 18, 2020

COVID-19 Trial in Canada (Artesunate, Imatinib, Infliximab)

Recruiting
  • COVID-19
  • Calgary, Alberta, Canada
  • +56 more
Jan 12, 2023